- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT01147367
Physical Activity, Fatigue, Sleep, and Inflammation (ABLE)
Physical Activity Benefits After Breast Cancer: Exploring Cytokine Mechanisms
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Detailní popis
Our previous research has shown that increases in physical activity can improve the health and well-being of breast cancer survivors. The current study will determine whether the physical activity increases are adequate for improved health by measuring physical activity (accelerometer and self-report), muscle strength, fatigue, and sleep. Moreover, few studies have examined cytokine changes in cancer survivors after participation in a physical activity behavior change intervention with a mechanistic focus on cytokines which may influence the muscle strength, fatigue, and sleep response to the intervention.
Seventy-four female, breast cancer survivors are being recruited within a 50-miles radius of Springfield, IL. Participants will be in the study for approximately 5 months. Participants will be asked to complete a questionnaire at the beginning of the study and 3 months later. A blood sample will be drawn to determine serum cytokine levels.
Volunteers will be randomly assigned to 1 of 2 study groups. The intervention group will participate in a 3 month physical activity intervention involving moderate intensity walking and strength training with resistance bands.
This randomized controlled trial includes the following study aims:
Study aim 1: The intervention group will be compared with the control group to examine the change in physical activity, muscle strength, fatigue, and sleep dysfunction before and after participation in a physical activity intervention.
Study aim 2: To investigate mechanisms that may underlie the effects of the physical activity intervention on muscle strength, fatigue, and sleep, we will compare the intervention group with the control group in terms of changes in cytokine markers of inflammation and evaluate whether such changes are consistent with and may mediate changes in muscle strength, fatigue, and sleep dysfunction.
Typ studie
Zápis (Aktuální)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
Illinois
-
Springfield, Illinois, Spojené státy, 62702
- Southern Illinois University School of Medicine
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- Female, 30 to 70 years of age, with first diagnosis of ductal carcinoma in situ (DCIS) or Stage I or Stage II breast cancer
- If chemotherapy or radiation therapy was received, the patient must be at least 4 weeks status post final primary treatment administration to allow treatment related cytokine changes to resolve. The participant may be taking longer term therapies such as aromatase inhibitors, estrogen receptor modulators, etc.
- If the patient has undergone a surgical procedure, she must be at least 8 weeks post-procedure.
- English speaking
- Medical clearance for participation provided by primary care physician or oncologist
- Postmenopausal
- Average fatigue over the past week of ≥ 3 on a 1 to 10 Likert scale or sleep dysfunction ≥ 1 on a 0 to 3 Likert scale
- Participating, on average, in no more than 20 minutes of physical activity on two or fewer days per week during the past six months
- Willing to abstain from "as needed" medications for 7 days prior to each blood draw. "As needed" medications are defined as any medicine (prescription or over-the-counter) that is taken sporadically as needed for specific complaints rather than taken at regularly scheduled intervals (e.g., daily).
Exclusion Criteria:
- Metastatic or recurrent breast cancer
- Inability to ambulate without assistance
- Unstable angina
- New York Heart Association class II, III, or IV congestive heart failure
- Uncontrolled asthma
- Interstitial lung disease
- Current use of steroids
- Having been told by a physician to only do exercise prescribed by a physician
- Dementia or organic brain syndrome
- Schizophrenia or active psychosis
- Connective tissue or rheumatologic disease [i.e., Systemic lupus erythematosus, rheumatoid arthritis, amyloidosis, Reiter's syndrome, psoriatic arthritis, mixed connective tissue disease, Sjögren's syndrome, progressive systemic sclerosis, CREST syndrome, polymyositis, dermatomyositis, vasculitis, polymyalgia rheumatic, temporal arteritis]
- Anticipates undergoing elective surgery during the duration of the intervention which would interfere with intervention participation (e.g., breast reconstructive surgery).
- Do not live or work less than 50 miles from the study site
- Lack of transportation to the study site
- Changes in usual medications expected during the study time period
- Plan to move residence out of the local area during the 5 months of the study
- Plan to travel out of the local area for vacation during the first 4 weeks of the intervention or plan to travel out of the local area for more than a week during the last 8 weeks of the intervention
- Contraindication to participation in physical activity (i.e., moderate intensity walking and strength training with resistance bands)
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Podpůrná péče
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
---|---|
Žádný zásah: Control
no physical activity intervention
|
|
Experimentální: Exercise intervention
3 month physical activity intervention involving moderate intensity walking and strength training with resistance bands
|
3 month physical activity intervention involving moderate intensity walking and strength training with resistance bands
Ostatní jména:
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
---|---|---|
physical activity
Časové okno: baseline and 3 months
|
The intervention group will be compared with the control group to examine the change in physical activity, before and after participation in a physical activity intervention.
Participants are in the study for approximately 5 months.
Assessments will be conducted at baseline, and following the 3 month exercise intervention.
|
baseline and 3 months
|
muscle strength
Časové okno: baseline and 3 months
|
The intervention group will be compared with the control group to examine the change in muscle strength before and after participation in a physical activity intervention.
|
baseline and 3 months
|
fatigue
Časové okno: baseline and 3 months
|
The intervention group will be compared with the control group to examine the change in fatigue before and after participation in a physical activity intervention.
|
baseline and 3 months
|
sleep dysfunction
Časové okno: baseline and 3 months
|
The intervention group will be compared with the control group to examine the change in sleep dysfunction before and after participation in a physical activity intervention.
|
baseline and 3 months
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
---|---|---|
inflammatory markers (serum cytokine levels)
Časové okno: baseline and 3 months
|
The study will also examine whether changes in inflammatory markers mediate improvements in the outcome measures of muscle strength, fatigue, and sleep dysfunction.
Blood samples with no potential for extraction of DNA will be collected.
|
baseline and 3 months
|
Spolupracovníci a vyšetřovatelé
Spolupracovníci
Publikace a užitečné odkazy
Obecné publikace
- Rogers LQ, Vicari S, Trammell R, Hopkins-Price P, Fogleman A, Spenner A, Rao K, Courneya KS, Hoelzer KS, Robbs R, Verhulst S. Biobehavioral factors mediate exercise effects on fatigue in breast cancer survivors. Med Sci Sports Exerc. 2014 Jun;46(6):1077-88. doi: 10.1249/MSS.0000000000000210.
- Rogers LQ, Fogleman A, Trammell R, Hopkins-Price P, Spenner A, Vicari S, Rao K, Courneya KS, Hoelzer K, Robbs R, Verhulst S. Inflammation and psychosocial factors mediate exercise effects on sleep quality in breast cancer survivors: pilot randomized controlled trial. Psychooncology. 2015 Mar;24(3):302-10. doi: 10.1002/pon.3594. Epub 2014 Jun 11.
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Odhad)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- ROG-SCCI-10-004-1
- R21CA135017-01A2 (Grant/smlouva NIH USA)
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Rakovina prsu
-
Tianjin Medical University Cancer Institute and...Guangxi Medical University; Sun Yat-sen University; Chinese PLA General Hospital a další spolupracovníciDokončenoPrůvodce klinickou aplikací Conebeam Breast CTČína
-
Gangnam Severance HospitalNáborHER2 Enriched Subtype Cancer Breast, Herzuma, PAM50 StudyKorejská republika
-
BioNTech SESeventh Framework ProgrammeDokončenoRakovina prsu (Triple Negative Breast Cancer (TNBC))Švédsko, Německo
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)NáborAnatomický karcinom prsu stadia II AJCC v8 | Anatomický karcinom prsu stadia III AJCC v8 | Rané stadium karcinomu prsu | Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8Spojené státy
-
Emory UniversityNational Cancer Institute (NCI)StaženoPrognostický karcinom prsu stadia IV AJCC v8 | Metastatický maligní novotvar v mozku | Metastatický karcinom prsu | Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8
-
NRG OncologyNational Cancer Institute (NCI)Aktivní, ne náborAnatomický karcinom prsu stadia IV AJCC v8 | Prognostický karcinom prsu stadia IV AJCC v8 | Metastatický maligní novotvar v kosti | Metastatický maligní novotvar v lymfatických uzlinách | Metastatický maligní novotvar v játrech | Metastatický karcinom prsu | Metastatický maligní novotvar v plicích | Metastatický... a další podmínkySpojené státy, Kanada, Saudská arábie, Korejská republika
Klinické studie na 3 month physical activity intervention
-
University of Alabama at BirminghamCenters for Disease Control and PreventionNáborRodinné vztahy | PlíseňSpojené státy
-
AbbVie (prior sponsor, Abbott)DokončenoCentrální předčasná puberta (CPP) | Předčasný | Leuprolid acetát | Luteinizační hormon (LH) | Agonista hormonu uvolňujícího gonadotropiny (GnRHa) | Tanner Staging | Depotní formulace | Potlačení LH | Hormon uvolňující gonadotropin (GnRH) | Lupron | GnRH analog | Pediatrie centrální předčasná pubertaSpojené státy, Portoriko
-
KK Women's and Children's HospitalNeznámýEmoční pohoda prvorodiček | Nutriční zdraví matky a dítěte | Rodičovská sebeúčinnost pro prvorodičky | Zkušenosti prvorodičekSingapur
-
Washington University School of MedicineNational Heart, Lung, and Blood Institute (NHLBI)DokončenoHypertenze | Nadváha | Dyslipidemie | Prediabetický stav | Metabolický syndrom XSpojené státy